IL62161A - Iminium salts,their preparation,pharmaceutical compositions containing them and their use as intermediates for preparing 5-cyano-(or-carbamyl)-(3,4'-bipyridin)-6(1h)-one - Google Patents

Iminium salts,their preparation,pharmaceutical compositions containing them and their use as intermediates for preparing 5-cyano-(or-carbamyl)-(3,4'-bipyridin)-6(1h)-one

Info

Publication number
IL62161A
IL62161A IL62161A IL6216181A IL62161A IL 62161 A IL62161 A IL 62161A IL 62161 A IL62161 A IL 62161A IL 6216181 A IL6216181 A IL 6216181A IL 62161 A IL62161 A IL 62161A
Authority
IL
Israel
Prior art keywords
bipyridin
carbamyl
intermediates
cyano
preparing
Prior art date
Application number
IL62161A
Other languages
English (en)
Other versions
IL62161A0 (en
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of IL62161A0 publication Critical patent/IL62161A0/xx
Publication of IL62161A publication Critical patent/IL62161A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL62161A 1980-02-26 1981-02-18 Iminium salts,their preparation,pharmaceutical compositions containing them and their use as intermediates for preparing 5-cyano-(or-carbamyl)-(3,4'-bipyridin)-6(1h)-one IL62161A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (2)

Publication Number Publication Date
IL62161A0 IL62161A0 (en) 1981-03-31
IL62161A true IL62161A (en) 1984-06-29

Family

ID=22416880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62161A IL62161A (en) 1980-02-26 1981-02-18 Iminium salts,their preparation,pharmaceutical compositions containing them and their use as intermediates for preparing 5-cyano-(or-carbamyl)-(3,4'-bipyridin)-6(1h)-one

Country Status (28)

Country Link
US (1) US4264609A (de)
JP (1) JPS56128758A (de)
KR (2) KR840002067B1 (de)
AR (1) AR230630A1 (de)
AT (2) AT380237B (de)
AU (1) AU541644B2 (de)
BE (1) BE887663A (de)
CA (1) CA1128523A (de)
CH (1) CH647509A5 (de)
DE (1) DE3107306A1 (de)
DK (1) DK171253B1 (de)
ES (1) ES499776A1 (de)
FI (1) FI76787C (de)
FR (1) FR2476646A1 (de)
GB (1) GB2070600B (de)
HK (1) HK71789A (de)
IE (1) IE51696B1 (de)
IL (1) IL62161A (de)
IT (1) IT1210992B (de)
LU (1) LU83169A1 (de)
MX (1) MX6908E (de)
NL (1) NL192109C (de)
NO (1) NO156689C (de)
NZ (1) NZ196282A (de)
PH (2) PH19904A (de)
PT (1) PT72573B (de)
SE (2) SE437514B (de)
ZA (1) ZA811124B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024B1 (de) 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
AU6748781A (en) 1981-09-03
NZ196282A (en) 1983-12-16
IT8119952A0 (it) 1981-02-24
DK171253B1 (da) 1996-08-12
PH19904A (en) 1986-08-13
KR830005143A (ko) 1983-08-03
HK71789A (en) 1989-09-14
IE51696B1 (en) 1987-02-18
SE8402727D0 (sv) 1984-05-21
FI76787C (fi) 1988-12-12
IT1210992B (it) 1989-09-29
US4264609A (en) 1981-04-28
CH647509A5 (fr) 1985-01-31
CA1128523A (en) 1982-07-27
LU83169A1 (fr) 1981-09-11
PT72573B (en) 1982-02-12
DE3107306C2 (de) 1990-11-29
NO810639L (no) 1981-08-27
NO156689C (no) 1987-11-04
AR230630A1 (es) 1984-05-31
FI810582L (fi) 1981-08-27
NO156689B (no) 1987-07-27
SE452764B (sv) 1987-12-14
DK83981A (da) 1981-08-27
DE3107306A1 (de) 1981-12-17
BE887663A (fr) 1981-08-25
AT380236B (de) 1986-04-25
MX6908E (es) 1986-11-07
FR2476646B1 (de) 1984-08-17
NL192109B (nl) 1996-10-01
FR2476646A1 (fr) 1981-08-28
ES499776A1 (es) 1984-06-16
IE810397L (en) 1981-08-26
IL62161A0 (en) 1981-03-31
AT380237B (de) 1986-04-25
PH17145A (en) 1984-06-04
ATA305683A (de) 1985-09-15
GB2070600B (en) 1984-07-11
SE437514B (sv) 1985-03-04
PT72573A (pt) 1981-03-01
ATA88581A (de) 1985-09-15
NL8100922A (nl) 1981-09-16
SE8101205L (sv) 1981-08-27
ZA811124B (en) 1982-03-31
KR840002066B1 (ko) 1984-11-09
SE8402727L (sv) 1984-05-21
KR840002067B1 (ko) 1984-11-09
JPH0141626B2 (de) 1989-09-06
AU541644B2 (en) 1985-01-17
GB2070600A (en) 1981-09-09
NL192109C (nl) 1997-02-04
JPS56128758A (en) 1981-10-08
FI76787B (fi) 1988-08-31

Similar Documents

Publication Publication Date Title
IL64665A (en) 4-amino-6,7-dimethoxy-2-piperazino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL60086A0 (en) Pyrimidine compounds,their preparation and pharmaceutical compositions containing them
DE3163938D1 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL62246A (en) 2(1h)-pyridinone derivatives,their preparation and pharmaceutical compositions containing them
IL74244A0 (en) Quinoline and naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3068706D1 (en) Novel benzodiazepine compounds, their preparation, intermediates employed in their preparation, and pharmaceutical compositions containing them
IL75733A0 (en) 1,6-naphthyridin-2(1h)-ones,their preparation and pharmaceutical compositions containing them
IL60472A0 (en) Substituted heterocyclic phenoxy-amines,their preparation and pharmaceutical compositions containing them
DE3160987D1 (en) Benzodiazepine derivatives, intermediates and processes for preparing them, their use and pharmaceutical compositions containing them
IL68710A (en) 2-(1h)-pyridinone derivatives,their preparation and pharmaceutical compositions containing them
DE3173643D1 (en) Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and intermediates for their preparation
DE3160986D1 (en) Benzodiazepine derivatives, intermediates and processes for preparing them, their use and pharmaceutical compositions containing them
EP0043054A3 (en) Pyrimidine derivatives, their preparation and use, medicaments containing them and intermediates for their preparation
JPS57123164A (en) Hydroxyphenyltetrahydropyridine novel derivatives and their salts, manufacture and intermediates, use as drug and composition containing same
IL62970A (en) Substituted phenoxy-aminopropanol derivatives and intermediates therefor,their preparation and pharmaceutical compositions containing them
IL62161A (en) Iminium salts,their preparation,pharmaceutical compositions containing them and their use as intermediates for preparing 5-cyano-(or-carbamyl)-(3,4'-bipyridin)-6(1h)-one
IL63607A (en) 4'-acylamino vlb derivatives,their preparation and pharmaceutical compositions containing them
SG62087G (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL72555A (en) 5-substituted-1,6-naphthyridin-2(1h)-one derivatives,their preparation,pharmaceutical compositions containing them and intermediates therefor
DE3171021D1 (en) Pyrrolo-(3,4-d)-benzapines, process and intermediates for their preparation and pharmaceutical compositions containing them
IL64328A0 (en) Naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
HK90387A (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL62159A0 (en) Preparation of 5-cyano-(3,4'-bipyridin)-6(1h)-one
ZA853268B (en) New quinoline derivatives,their preparation and therapeutic compositions containing the same
IL64672A0 (en) Substituted tetrahydro-1,2,4-oxadiazin-5-one derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
HP Change in proprietorship
KB Patent renewed
HC Change of name of proprietor(s)
EXP Patent expired